| Financial Year |
March 31 2023 |
| Monetary Funds |
658,207,715.46 |
| Held-for-trading Financial Assets |
99,476,088.30 |
| Notes Receivable |
1,280,479.71 |
| Accounts Receivable |
350,697,567.90 |
| Advances to Suppliers |
78,341,392.68 |
| Other Receivables |
126,186,999.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,040,722.98 |
| Dividend Receivable |
-- |
| Inventories |
106,441,673.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,425,126.80 |
| Total Current Assets |
1,447,273,328.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
850,000,000.00 |
| Investment Properties |
17,978,242.82 |
| Fixed Assetes |
137,466,218.54 |
| Under-construction Projects |
64,152,653.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
991,678,922.99 |
| R&D expenses |
-- |
| Goodwill |
10,119,975.52 |
| Long-Term Deferred and Prepaid Expenses |
11,818,165.39 |
| Deferred Income Tax Assets |
60,900,281.70 |
| Other Non-Current Assets |
115,607,722.21 |
| Sub-Total of Non-Current Assets |
2,527,005,879.87 |
| Total Assets |
3,974,279,208.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
130,202,874.13 |
| Accounts Received In Advance |
59,594.83 |
| Employee Compensation Payable |
3,761,366.45 |
| Taxes Payable |
5,606,715.33 |
| Interest Payable |
17,937.20 |
| Dividend Payable |
778,960.00 |
| Other payables |
338,052,875.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,108,296.47 |
| Other Current Liabilities |
4,709,179.70 |
| Sub-Total of Current Liabilities |
555,637,697.18 |
| Long-term Loans |
140,056,666.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
62,905.00 |
| Deferred Income Tax Liabilities |
917,873.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
245,653,596.91 |
| Total Liabilities |
801,291,294.09 |
| Paid-In Capital(Or Share Stock) |
1,613,781,103.00 |
| Capital Surplus |
1,982,459,588.94 |
| Surplus Reserve |
30,601,343.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-408,169,639.09 |
| Minority Stockholder's Interest |
13,353,887.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,159,634,027.06 |
| Owner's Equity（Stockholder's Equity） |
3,172,987,914.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,974,279,208.29 |
